Logo image of MEGL

MAGIC EMPIRE GLOBAL LTD (MEGL) Stock Fundamental Analysis

NASDAQ:MEGL - Nasdaq - VGG5865E1051 - Common Stock - Currency: USD

0.58  +0.01 (+1.58%)

Fundamental Rating

3

Taking everything into account, MEGL scores 3 out of 10 in our fundamental rating. MEGL was compared to 222 industry peers in the Capital Markets industry. While MEGL has a great health rating, there are worries on its profitability. MEGL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year MEGL has reported negative net income.
MEGL had a positive operating cash flow in the past year.
In multiple years MEGL reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MEGL reported negative operating cash flow in multiple years.
MEGL Yearly Net Income VS EBIT VS OCF VS FCFMEGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

MEGL has a Return On Assets of -0.35%. This is in the lower half of the industry: MEGL underperforms 78.80% of its industry peers.
MEGL has a worse Return On Equity (-0.36%) than 75.58% of its industry peers.
Industry RankSector Rank
ROA -0.35%
ROE -0.36%
ROIC N/A
ROA(3y)1.04%
ROA(5y)13.63%
ROE(3y)8.52%
ROE(5y)83.85%
ROIC(3y)N/A
ROIC(5y)N/A
MEGL Yearly ROA, ROE, ROICMEGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 100 150 200 250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MEGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEGL Yearly Profit, Operating, Gross MarginsMEGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, MEGL has less shares outstanding
There is no outstanding debt for MEGL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MEGL Yearly Shares OutstandingMEGL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M
MEGL Yearly Total Debt VS Total AssetsMEGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

MEGL has an Altman-Z score of 14.34. This indicates that MEGL is financially healthy and has little risk of bankruptcy at the moment.
MEGL has a Altman-Z score of 14.34. This is amongst the best in the industry. MEGL outperforms 97.23% of its industry peers.
MEGL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.34
ROIC/WACCN/A
WACCN/A
MEGL Yearly LT Debt VS Equity VS FCFMEGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

MEGL has a Current Ratio of 24.13. This indicates that MEGL is financially healthy and has no problem in meeting its short term obligations.
MEGL has a better Current ratio (24.13) than 99.08% of its industry peers.
MEGL has a Quick Ratio of 24.13. This indicates that MEGL is financially healthy and has no problem in meeting its short term obligations.
MEGL has a Quick ratio of 24.13. This is amongst the best in the industry. MEGL outperforms 99.08% of its industry peers.
Industry RankSector Rank
Current Ratio 24.13
Quick Ratio 24.13
MEGL Yearly Current Assets VS Current LiabilitesMEGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.59% over the past year.
MEGL shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.13%.
The Revenue for MEGL have been decreasing by -12.26% on average. This is quite bad
EPS 1Y (TTM)89.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.01%
Revenue 1Y (TTM)23.13%
Revenue growth 3Y-12.26%
Revenue growth 5YN/A
Sales Q2Q%130.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEGL Yearly Revenue VS EstimatesMEGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MEGL Yearly EPS VS EstimatesMEGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
MEGL Price Earnings VS Forward Price EarningsMEGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MEGL Per share dataMEGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MEGL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAGIC EMPIRE GLOBAL LTD

NASDAQ:MEGL (1/29/2025, 2:36:52 PM)

0.58

+0.01 (+1.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners0.43%
Inst Owner ChangeN/A
Ins Owners52.41%
Ins Owner ChangeN/A
Market Cap11.75M
AnalystsN/A
Price TargetN/A
Short Float %0.94%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-328.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.64
P/FCF N/A
P/OCF 968.88
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFY0.1%
SpS0.09
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -0.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.04%
ROA(5y)13.63%
ROE(3y)8.52%
ROE(5y)83.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 907.26%
Cap/Sales 13.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.13
Quick Ratio 24.13
Altman-Z 14.34
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.01%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.13%
Revenue growth 3Y-12.26%
Revenue growth 5YN/A
Sales Q2Q%130.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.38%
OCF growth 3YN/A
OCF growth 5YN/A